Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose chewable tablets in type 2 diabetes
ChiCTR-TRC-11001534Phase 2Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2009
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acarbose in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: HbA1c. Started Jul 2009; status: completed.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-11001534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001534.